Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage

Digestive Diseases and Sciences

Volumn 42, Issue 10, 1997, Pages 2054-2063

  Lu, Zhao ^b   Friess, Helmut ^a   Graber, Hans U ^b   Guo, Xiaozhong ^b   Schilling, Martin ^b   Zimmermann, Arthur ^b   Korc, Murray ^b   Büchler, Markus W ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

Immunohistochemistry; In situ hybridization; Northern blot analysis; Pancreatic cancer; Transforming growth factor receptors

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NORTHERN BLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030827414     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018814416903     Document Type: Article

References (42)

1. Silverberg E, Boring CC, Squires TS: Cancer statistics. CA Cancer J Clin 40:9-26, 1990
2. Bornman PC, Krige JEJ: Prognosis in carcinoma of the pancreas. Dig Surg 11:342-345, 1994
3. Büchler M, Friess H, Schultheiss KH, Gebhardt CH, Muhrer KH, Winkelmann M, Wagener T, Klapdor R, Kaul M, Müller G, Schulz G, Beger HG: A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer. Cancer 68:1507-1512, 1991
4. Friess H, Büchler M, Krüger M, Beger HG: Treatment of duct carcinoma of the pancreas with the LH-RH-analogue buserelin. Pancreas 7:516-521, 1992
5. Massagué J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641, 1990
6. Lamprecht SA, Schwartz B, Glicksman A: Transforming growth factor-beta in intestinal epithelial differentiation and neoplasia. Anticancer Res 9:1877-1881, 1989
7. Attisano L, Wrana JL, López-Casillas F, Massagué J: TGF-β receptors and actions. Biochim Biophys Acta 1222:71-80, 1994
8. Massagué J: Receptors for the TGF-β family. Cell 69:1067-1070, 1992
9. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF: Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785, 1992
10. Franzén P, ten Dijke, Ichijo H, Zamashita H, Schulz P, Heldin CH, Miyazono K: Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75:681-692, 1993
11. ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, Heldin CH: Characterization of type I receptors for transforming growth factor beta and activin. Science 264:101-104, 1994
12. Matsuzaki K, Xu J, Wang F, Mckeehan WL, Krummen L, Kan M: A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor-β, or bone morphogenic factor. J Biol Chem 268:12719-12723, 1993
13. Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R: Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260:1344-1348, 1993
14. Friess H, Yamanaka Y, Büchler M, Beger HG, Kobrin MS, Baldwin RL, Korc M: Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res 53:2704-2707, 1993
15. Baldwin RL, Friess H, Yokoyama M, Lopez ME, Kobrin MS, Büchler M, Korc M: Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int J Cancer 67:283-288, 1996
16. Hermanek P, Scheibe O, Spiessl B, Wagner G: TNM Klassifikation maligner tumoren. New York, Springer, 1987
17. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Büchler M, Beger HG: Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 90:1352-1360, 1992
18. Deflorin J, Friess H, Schobinger S, Bründler MA, Schilling M, Naef M, Korc M, Buchler MW: Overexpression of the epidermal growth factor receptor family in gastric cancer suggests a role in tumor pathogenesis. Dig Surg 14:252-259, 1997
19. Graber HU, Müller CF, Vandevelde M: Restricted infection with canine distemper virus leads to down-regulation of myelin gene transcription in cultured oligodendrocytes. Acta Neuropathol 90:312-318, 1995
20. Glinsmann-Gibson BJ, Korc M: Regulation of transforming growth factor-alpha mRNA expression in T3M4 human pancreatic carcinoma cells. Pancreas 6:142-149, 1991
21. Cox KH, DeLeon DV, Angerer LM, Angerer RC: Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 101:485-502, 1984
22. Friess H, Yamanaka Y, Büchler M, Ebert M, Beger HG, Gold LI, Korc M: Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105:1846-1856, 1993
23. Gress TM, Müller-Pillasch F, Lerch MM, Friess H, Büchler M, Adler G: Expression and in situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer 62:407-413, 1995
24. Yang EY, Moses HL: Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111:731-741, 1990
25. Sporn MB, Roberts AB: TGF-β: Problems and prospects. Cell Regul 1:875-882, 1990
26. Hirayama D, Fujimori T, Satonaka K, Nakamura T, Kitazawa S, Horio M, Maeda S, Nagasako K: Immunohistochemical study of epidermal growth factor and transforming growth factor-β in the penetrating type of early gastric cancer. Hum Pathol 23:681-685, 1992
27. 1 associates with disease progression in human breast cancer. Cancer Res 52:6449-6952, 1992
28. Jasani B, Wyllie FS, Wright PA, Lemoine NR, Williams ED, Wynford-Thomas D: Immunocytochemically detectable TGF-β is associated with malignancy in thyroid epithelial neoplasia. Growth Factors 2:149-155, 1990
29. Johnson MD, Federspiel CF, Gold LI, Moses HL: Transforming growth factor-β and transforming growth factor β receptor expression in human meningioma cells. Am J Pathol 141:633-642, 1992
30. Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB, Sporn MB: Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci USA 91:8772-8776, 1994
31. Kadin ME, Cavaille-Coll MW, Gertz R, Massague J, Cheifetz S, George D: Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc Natl Acad Sci USA 91:6002-6006, 1994
32. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C: Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res 56:44-48, 1996
33. Wang J, Han W, Zborowska E, Liang J, Wang X, Willson JKV, Sun L, Brattain MG: Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem 271:17366-17371, 1996
34. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Wilson JKV: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995
35. Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, Bang Y-J, Lee Hw, Park J-G, Lynch HAT, Roberts AB, Vogelstein B, Markowitz SD: A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55:5545-5547, 1995
36. Boyer JC, Umar A, Risinger JI, Lipford JR, Kane M, Yin S, Barrett JC, Kolodner RD, Kunkel TA: Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res 55:6063-6070, 1995
37. Reisenbichler H, Chari RS, Boyer IJ, Jirtle RL: Transforming growth factor-beta receptors type I, II and III in phenobarbital-promoted rat liver tumors. Carcinogenesis 15:2763-2767, 1994
38. Valverius EM, Walker-Jones D, Bates SE, Stampfer MR, Clark R, McCormick F, Dickson RB, Lippman ME: Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. Cancer Res 49:6269-6274, 1989
39. Wyllie FS, Dawson T, Bond JA, Goretzki P, Game S, Prime S, Wynford-Thomas D: Correlated abnormalities of transforming growth factor-β1 response and p53 expression in thyroid epithelial cell transformation. Mol Cell Endocrinol 76:13-21, 1991
40. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353, 1996
41. Yokoyama M, Yamanaka Y, Friess H, Büchler M, Korc M: p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness. Anticancer Res 14:2477-2483, 1944
42. Casey G, Yamanaka Y, Friess H, Kobrin MS, Lopez ME, Büchler M, Beger HG, Korc M: p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett 69:151-160, 1993